Search research articles
Contact Us
Filters
Showing results (151-160 of 208) with videos related to
Page
of 21
Sort By:
European Urology Oncology
|
July 8, 2026
Molecular Profiling of Urothelial Bladder Cancer: Bridging Tumor Biology and Clinical Decision-making
Constance Thibault, Hélène Blons, Yves Allory, et al.
The French Journal of Urology
|
April 17, 2026
Guidelines from the cancer (CCAFU) and infection disease (CI-AFU) committees of the French association of Urology for the management of adverse events and complications of BCG
Priscilla Leon, Laura I Levi, Thibaut Long Depaquit, et al.
European Urology
|
October 5, 2015
Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas
Julien Calderaro, Julien Masliah-Planchon, Wilfrid Richer, et al.
Annals of Surgical Oncology
|
May 10, 2026
Robot-Assisted Versus Open Bladder Cuff Excision After Radical Nephroureterectomy: A Multicenter Study by the French Urothelial Cancer Committee
Pierre-Etienne Gabriel, Thomas Seisen, Evanguelos Xylinas, et al.
The Journal of Pathology
|
March 17, 2012
CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma
Sandra Rebouissou, Aurélie Hérault, Eric Letouzé, et al.
International Journal of Surgical Pathology
|
April 25, 2022
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis
Laura S Mertens, Francesco Claps, Roman Mayr, et al.
European Urology Oncology
|
April 16, 2025
Challenges in Defining Clinical Complete Response to Systemic Therapy in Muscle-invasive Bladder Cancer: Insights from the EORTC STARBURST Project
Alexandra Masson-Lecomte, Guillaume Grisay, Julien Van Damme, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 13, 2023
Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24)
Constance Thibault, Aude Fléchon, Laurence Albiges, et al.
Cancers
|
November 11, 2022
Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee
Alexandra Masson-Lecomte, Victoire Vaillant, Mathieu Roumiguié, et al.
Cell Reports
|
December 3, 2014
Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes
Anne Biton, Isabelle Bernard-Pierrot, Yinjun Lou, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 208) with videos related to
Sort By:
Page
of 21
European Urology Oncology
|
July 8, 2026
Molecular Profiling of Urothelial Bladder Cancer: Bridging Tumor Biology and Clinical Decision-making
Constance Thibault, Hélène Blons, Yves Allory, et al.
The French Journal of Urology
|
April 17, 2026
Guidelines from the cancer (CCAFU) and infection disease (CI-AFU) committees of the French association of Urology for the management of adverse events and complications of BCG
Priscilla Leon, Laura I Levi, Thibaut Long Depaquit, et al.
European Urology
|
October 5, 2015
Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas
Julien Calderaro, Julien Masliah-Planchon, Wilfrid Richer, et al.
Annals of Surgical Oncology
|
May 10, 2026
Robot-Assisted Versus Open Bladder Cuff Excision After Radical Nephroureterectomy: A Multicenter Study by the French Urothelial Cancer Committee
Pierre-Etienne Gabriel, Thomas Seisen, Evanguelos Xylinas, et al.
The Journal of Pathology
|
March 17, 2012
CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma
Sandra Rebouissou, Aurélie Hérault, Eric Letouzé, et al.
International Journal of Surgical Pathology
|
April 25, 2022
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis
Laura S Mertens, Francesco Claps, Roman Mayr, et al.
European Urology Oncology
|
April 16, 2025
Challenges in Defining Clinical Complete Response to Systemic Therapy in Muscle-invasive Bladder Cancer: Insights from the EORTC STARBURST Project
Alexandra Masson-Lecomte, Guillaume Grisay, Julien Van Damme, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 13, 2023
Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24)
Constance Thibault, Aude Fléchon, Laurence Albiges, et al.
Cancers
|
November 11, 2022
Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee
Alexandra Masson-Lecomte, Victoire Vaillant, Mathieu Roumiguié, et al.
Cell Reports
|
December 3, 2014
Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes
Anne Biton, Isabelle Bernard-Pierrot, Yinjun Lou, et al.
Page
of 21